Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Jun-24 4:22 PM View:  | Schrodinger, Inc. (SDGR) | 18-Jun-24 | Grant | 5,000 | -- | -- | 80% 6.25K to 11.25K | |
| 07-Jun-24 4:07 PM View: | Adicet Bio, Inc. (ACET) | 05-Jun-24 | Grant | 5,900 | -- | -- | 100% 5.9K to 11.8K | |
| 02-Jun-23 5:50 PM View: | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
| 14-Feb-18 6:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-18 | Market Sale (Planned) | 5,122 | $150.82 | $772,493.00 | (7%) 74.78K to 69.66K | (16%) |
| 08-Feb-18 5:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-18 | Grant | 22,261 | -- | -- | 42% 52.52K to 74.78K | |
| 07-Feb-18 6:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-18 | Option Exercise | 3,594 | $109.14 | $392,249.00 | 7% 52.52K to 56.12K | |
| 07-Feb-18 6:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-18 | Market Option Sale (Planned) | 3,594 | $161.46 | $580,304.00 | (6%) 56.12K to 52.52K | (8%) |
| 05-Feb-18 5:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-18 | Option Exercise | 1,796 | $91.05 | $163,526.00 | 3% 52.52K to 54.32K | |
| 05-Feb-18 5:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-18 | Market Sale (Planned) | 1,796 | $166.11 | $298,329.00 | (3%) 54.32K to 52.52K | (5%) |
| 05-Feb-18 5:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-18 | Market Option Sale (Planned) | 1,796 | $167.44 | $300,722.00 | (3%) 54.42K to 52.63K | (4%) |
| 05-Feb-18 5:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-18 | Market Sale (Planned) | 104 | $167.44 | $17,413.80 | (< 1%) 52.63K to 52.52K | (4%) |
| 17-Jan-18 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Jan-18 | Option Exercise | 1,719 | $96.87 | $166,520.00 | 3% 54.42K to 56.14K | |
| 17-Jan-18 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Jan-18 | Market Option Sale (Planned) | 1,719 | $157.28 | $270,358.00 | (3%) 56.14K to 54.42K | (11%) |
| 03-Jan-18 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Jan-18 | Option Exercise | 3,438 | $73.51 | $252,727.00 | 6% 54.42K to 57.86K | |
| 03-Jan-18 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Jan-18 | Market Option Sale (Planned) | 3,438 | $151.80 | $521,895.00 | (6%) 57.86K to 54.42K | (15%) |
| 06-Nov-17 5:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Nov-17 | Option Exercise | 3,594 | $109.14 | $392,249.00 | 7% 54.42K to 58.02K | |
| 06-Nov-17 5:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Nov-17 | Market Option Sale (Planned) | 3,594 | $144.69 | $520,016.00 | (6%) 58.02K to 54.42K | (21%) |
| 06-Nov-17 5:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Nov-17 | Option Exercise | 1,796 | $91.05 | $163,526.00 | 3% 54.42K to 56.22K | |
| 06-Nov-17 5:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Nov-17 | Market Option Sale (Planned) | 1,796 | $144.76 | $259,982.00 | (3%) 56.22K to 54.42K | (21%) |
| 31-Oct-17 6:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Oct-17 | Market Sale (Planned) | 60,000 | $145.05 | $8,703,160.00 | (52%) 114.42K to 54.42K | (20%) |
| 18-Oct-17 5:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Oct-17 | Option Exercise | 1,718 | $96.87 | $166,423.00 | 2% 114.42K to 116.14K | |
| 18-Oct-17 5:35 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Oct-17 | Market Option Sale (Planned) | 1,718 | $155.19 | $266,610.00 | (1%) 116.14K to 114.42K | (13%) |
| 04-Oct-17 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Oct-17 | Option Exercise | 3,437 | $73.51 | $252,654.00 | 3% 114.42K to 117.86K | |
| 04-Oct-17 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Oct-17 | Market Option Sale (Planned) | 3,437 | $151.64 | $521,198.00 | (3%) 117.86K to 114.42K | (15%) |
| 04-Aug-17 4:42 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Aug-17 | Option Exercise | 3,594 | $109.14 | $392,249.00 | 3% 114.42K to 118.02K | |
| 04-Aug-17 4:42 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Aug-17 | Market Option Sale (Planned) | 3,594 | $154.19 | $554,149.00 | (3%) 118.02K to 114.42K | (13%) |
| 04-Aug-17 4:42 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Aug-17 | Option Exercise | 1,796 | $91.05 | $163,526.00 | 2% 114.42K to 116.22K | |
| 04-Aug-17 4:42 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Aug-17 | Market Option Sale (Planned) | 1,796 | $154.13 | $276,811.00 | (2%) 116.22K to 114.42K | (13%) |
| 21-Jul-17 8:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Jul-17 | Market Sale (Planned) | 6,900 | $160.73 | $1,109,020.00 | (6%) 121.32K to 114.42K | (9%) |
| 21-Jul-17 8:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jul-17 | Option Exercise | 38,646 | $107.14 | $4,140,490.00 | 32% 122.51K to 161.16K | |
| 21-Jul-17 8:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jul-17 | Market Option Sale (Planned) | 38,646 | $161.00 | $6,222,010.00 | (24%) 161.16K to 122.51K | (9%) |
| 21-Jul-17 8:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jul-17 | Market Sale (Planned) | 1,187 | $161.00 | $191,107.00 | (< 1%) 122.51K to 121.32K | (9%) |
| 19-Jul-17 4:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Jul-17 | Option Exercise | 573 | $96.87 | $55,506.50 | < 1% 122.51K to 123.08K | |
| 19-Jul-17 4:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Jul-17 | Market Option Sale (Planned) | 573 | $129.85 | $74,401.50 | (< 1%) 123.08K to 122.51K | (35%) |
| 06-Jul-17 4:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Jul-17 | Option Exercise | 3,438 | $73.51 | $252,727.00 | 3% 122.51K to 125.95K | |
| 06-Jul-17 4:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Jul-17 | Market Option Sale (Planned) | 3,438 | $127.80 | $439,379.00 | (3%) 125.95K to 122.51K | (37%) |
| 23-Jun-17 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Jun-17 | Option Exercise | 5,157 | $96.87 | $499,559.00 | 4% 122.51K to 127.67K | |
| 23-Jun-17 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Jun-17 | Market Option Sale (Planned) | 5,157 | $132.87 | $685,211.00 | (4%) 127.67K to 122.51K | (32%) |
| 05-Jun-17 6:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-17 | Option Exercise | 5,155 | $96.87 | $499,365.00 | 4% 122.51K to 127.67K | |
| 05-Jun-17 6:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Jun-17 | Market Option Sale (Planned) | 5,155 | $126.87 | $654,015.00 | (4%) 127.67K to 122.51K | (38%) |
| 04-May-17 8:51 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-May-17 | Option Exercise | 8,979 | $91.05 | $817,538.00 | 7% 122.51K to 131.49K | |
| 04-May-17 8:51 AM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-May-17 | Market Option Sale (Planned) | 8,979 | $121.05 | $1,086,910.00 | (7%) 131.49K to 122.51K | (44%) |
| 07-Apr-17 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Apr-17 | Option Exercise | 8,021 | $73.51 | $589,624.00 | 7% 122.51K to 130.53K | |
| 07-Apr-17 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Apr-17 | Market Option Sale (Planned) | 8,021 | $114.00 | $914,394.00 | (6%) 130.53K to 122.51K | (53%) |
| 05-Apr-17 4:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Apr-17 | Option Exercise | 2,291 | $73.51 | $168,411.00 | 2% 122.51K to 124.8K | |
| 05-Apr-17 4:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Apr-17 | Market Option Sale (Planned) | 2,291 | $108.85 | $249,383.00 | (2%) 124.8K to 122.51K | (61%) |
| 31-Mar-17 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Mar-17 | Option Exercise | 13,750 | $73.51 | $1,010,760.00 | 11% 122.51K to 136.26K | |
| 31-Mar-17 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Mar-17 | Market Option Sale (Planned) | 13,750 | $106.65 | $1,466,440.00 | (10%) 136.26K to 122.51K | (64%) |
| 15-Feb-17 4:42 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-17 | Market Sale (Planned) | 5,122 | $87.67 | $449,046.00 | (4%) 127.63K to 122.51K | (99%) |
| 07-Feb-17 4:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-17 | Grant | 16,930 | $0.00 | $47.94 | 15% 110.7K to 127.63K |